Pharma & Biotech
-
Yardley Chief Financial Officer Noses His Career in a New Direction
Optinose, the Yardley pharmaceutical company, has announced that Chief Financial Officer Keith A. Goldan has accepted a position at another public company. Optinose focuses on patients treated by ear, nose and throat (ENT) and allergy specialists. Chief Executive Officer Peter Miller stated, “On behalf of our entire team, I would like to thank Keith for…
-
Hatfield Biotechnology Startup Raises $75M to Develop Genetic Medicines
Hatfield-based Code Biotherapeutics recently raised $75 million to develop genetic medicines that are based on technology aimed at increasing the applicability of these types of treatments, writes Brian Gormley for The Wall Street Journal. The biotechnology startup delivers genetic medicines into cells using a proprietary technology it applies to its own therapeutics and those it…
-
Warrington CEO Makes National List of 50 Fastest-Growing Women-Owned Businesses
The corporate leadership shown by Donna Dorozinsky has caught the attention of the Women Presidents Organization (WPO) and JPMorgan Chase. The two institutions have named her one of the 50 fastest growing women-owned and -led companies in the U.S. Dorozinsky is President/CEO of Just in Time GCP in Warrington. The consulting firm helps biopharma companies…
-
Pa. Biotechnology Center: What Has Its Economic Impact Been over the Past Half Decade?
When first proposed in 2001, the Pennsylvania Biotechnology Center (PABC) in Doylestown was meant to stimulate scientific thought and innovation. It’s made good on that promise but has also proven valuable in a much broader sense. As one of the nation’s most successful life sciences incubators, the PABC and its member companies generated $7.3 billion…
-
Newtown Pharma Co. Has One Township Supervisor Wishing Its Principals Were ‘Better Corporate Citizens’
Newcomer drug manufacturer KVK Tech Inc. and its occupancy of the dormant Lockheed site were considered a Newtown boon in 2015. But it didn’t take long for that upbeat feeling to sink. Bob Fernandez uncapped the disappointment in The Philadelphia Inquirer. KVK’s takeover of the defense contractor’s abandoned Terry Drive property turned sour as the…
-
Doylestown Spinoff Leverages mRNA Tech to Address Hep B, Cancer, and Lyme Disease
Merlin Biotech of Doylestown will use its Blumberg Institute pedigree, its Pa. Biotechnology Center location, and the guidance of a former Moderna executive to get itself up and running as a spinoff entity. John George covered the firm’s next moves in the Philadelphia Business Journal. The company will leverage its experience with mRNA technology to…
-
Chesterbrook-Based Biopharmaceutical Company on Track for Massive Windfall
Trevena, a biopharmaceutical company based in Chesterbrook, has entered into a royalty-based financing deal with an affiliate of R-Bridge Healthcare Fund that could lead to a collection of $40 million, writes John George for the Philadelphia Business Journal. As a result, the company’s stock was up nearly 30 percent late last week. Trevena will receive $15…
-
Warrington’s Windtree Therapeutics Succeeds in Trial of COVID-Related Lung Distress Treatment
A Phase 2 test by Windtree Therapeutics of its drug treatment for Associated Acute Respiratory Distress Syndrome (ARDS) may hold hope for patients with damaged lungs. The trial results from the Warrington biopharma company could represent progress in healing lungs affected by COVID-19 and other conditions that cause a build-up of fluid that compromises breathing.…
-
Pa. Pharma Settlement Brings $45M to Bucks County’s Effort to Fight Addiction
Pa.’s pharma settlement negotiation with three major players in the area will infuse nearly $45 million in local efforts to curb addition. Peg Quann reported the litigation’s resolution in the Bucks County Courier Times. The county’s share comes from a $26 billion global settlement from three pharma distributors — Cardinal Health, McKesson, and AmerisourceBergen —…
-
Arbutus Biopharma Corp., Warminster, Files Patent Infringement Lawsuit over COVID-19 Vaccine
Arbutus Biopharma Corp., Warminster, has filed a patent infringement lawsuit against Moderna Inc. The claim seeks unspecified damages related to Moderna’s widely distributed COVID-19 vaccine. John George covered the action for the Philadelphia Business Journal. Arbutus Biopharma Corp. took action with affiliate Genevant Sciences Corp. (of Vancouver) for recompense from Moderna and a Moderna affiliate.…
-
Boathouse Row to Light Up for Rare Disease Day, Says King of Prussia’s CSL Behring CEO
“Our collective hope shines a light on the progress made and challenges ahead,” CSL Behring Limited CEO and Managing Director Paul Perreault said in a video message to 25,000 employees. “Today, the rare disease community joins together to recognize Rare Disease Day. It’s a day, above all, that represents connection and hope. On February 28th, as…
-
CSL Behring Partners with Uplifting Athletes for Rare Disease Research and Honors Those Making an Impact
At the celebratory event, presented by global biotherapies leader CSL Behring, Uplifting Athletes awarded $180,000 in research grants to nine promising young investigative rare disease researchers and honored the six newest members of the organization’s Rare Disease Championship Team―an exemplary group of college football players who support Uplifting Athletes’ mission to inspire the Rare Disease Community…
-
Doylestown Biotech Firm FlowMetric, Often Courted, Never Seriously Considered Selling… Until Now
FlowMetric, a Doylestown biotech company, has sold to a Kansas buyer. John George, Philadelphia Business Journal reported on FlowMetric’s sell decision, which came after numerous offers. The Bucks County company is a specialized contract research organization (CRO), meaning it outsources research services to businesses in industries that include pharma, biotech, and medical devices. Its buyer…
-
Abington Scientist Named A Time Magazine’s 2021 Heroes of the Year
Abington’s Katalin Kariko is one of the Heroes of the Year, a group of scientists who introduced an innovative and highly effective mRNA-based vaccine platform to the world that will have a huge impact on our health and well-being far beyond COVID-19, write Alice Park and Jamie Ducharme for Time. Kariko, a Hungary native, made…
-
IGM Biosciences Expands Silicon Valley Footprint by Stepping into Bucks County
IGM Biosciences of Mountain View, Calif. — nestled in the Silicon Valley between San Francisco and San Jose — is relocating one of its headquarters to the greener pastures of Doylestown. John George reported the eastbound moving vans for the Philadelphia Business Journal. IGM is relocating two business units to the Pennsylvania Biotechnology Center of…
-
Penn Medicine Gene Therapy Doctor Signs Deal with Center for Breakthrough Medicines in King of Prussia
University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to license its manufacturing process to King of Prussia’s Center for Breakthrough Medicines, writes Erin Arvedlund for The Philadelphia Inquirer. In turn, the center has the exclusive right to make the gene therapy lab’s process available…
-
NRx in Radnor Asks Again for Approval to Use Its COVID-19 Drug, Zyesami
NRx Pharmaceuticals out of Radnor has once again filed an application with the Food and Drug Administration for emergency use of its experimental COVID-19 drug candidate, Zyesami, writes John George for the Philadelphia Business Journal. The drug would be used on critical patients with COVID-19 who are at immediate risk of death from respiratory failure…
-
Warminster’s Arbutus Biopharma Strikes Licensing-Partnering Deal with Chinese Pharma Firm
Arbutus Biopharma, Warminster, has entered a $300 million licensing and partnership deal with a Chinese biopharmaceutical firm. enters into $300M deal for experimental hepatitis B drug with Chinese pharma firm. John George of the Philadelphia Business Journal covered the arrangement between the domestic firm and Qilu Pharmaceutical of Jinan. Under the pact, Qilu obtained exclusive…
Founding Partners
Advertisement
Affiliate Partners
